Skip to main content

Main menu

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Corporate & Special Sales
    • Journal Claims
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Continuing Education
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI

User menu

  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Journal of Nuclear Medicine
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Journal of Nuclear Medicine

Advanced Search

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Corporate & Special Sales
    • Journal Claims
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Continuing Education
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • Follow JNM on Twitter
  • Visit JNM on Facebook
  • Join JNM on LinkedIn
  • Subscribe to our RSS feeds

PET/CT

  • Comparison of Baseline <sup>68</sup>Ga-FAPI and <sup>18</sup>F-FDG PET/CT for Prediction of Response and Clinical Outcome in Patients with Unresectable Hepatocellular Carcinoma Treated with PD-1 Inhibitor and Lenvatinib
    You have access
    Comparison of Baseline 68Ga-FAPI and 18F-FDG PET/CT for Prediction of Response and Clinical Outcome in Patients with Unresectable Hepatocellular Carcinoma Treated with PD-1 Inhibitor and Lenvatinib
    Meiqi Wu, Yanyu Wang, Qiao Yang, Xuezhu Wang, Xu Yang, Haiqun Xing, Xinting Sang, Xiang Li, Haitao Zhao and Li Huo
    Journal of Nuclear Medicine July 27, 2023, jnumed.123.265712; DOI: https://doi.org/10.2967/jnumed.123.265712
  • You have access
    Fibroblast Activation Protein Inhibitor–Based Radionuclide Therapies: Current Status and Future Directions
    Manish Ora, Neetu Soni, Aftab Hasan Nazar, Manish Dixit, Rohit Singh, Savita Puri, Michael M. Graham and Sanjay Gambhir
    Journal of Nuclear Medicine July 1, 2023, 64 (7) 1001-1008; DOI: https://doi.org/10.2967/jnumed.123.265594
  • An Investigation of Lesion Detection Accuracy for Artificial Intelligence–Based Denoising of Low-Dose <sup>64</sup>Cu-DOTATATE PET Imaging in Patients with Neuroendocrine Neoplasms
    You have access
    An Investigation of Lesion Detection Accuracy for Artificial Intelligence–Based Denoising of Low-Dose 64Cu-DOTATATE PET Imaging in Patients with Neuroendocrine Neoplasms
    Mathias Loft, Claes N. Ladefoged, Camilla B. Johnbeck, Esben A. Carlsen, Peter Oturai, Seppo W. Langer, Ulrich Knigge, Flemming L. Andersen and Andreas Kjaer
    Journal of Nuclear Medicine June 1, 2023, 64 (6) 951-959; DOI: https://doi.org/10.2967/jnumed.122.264826
  • A Multicenter Study on Observed Discrepancies Between Vendor-Stated and PET-Measured <sup>90</sup>Y Activities for Both Glass and Resin Microsphere Devices
    You have access
    A Multicenter Study on Observed Discrepancies Between Vendor-Stated and PET-Measured 90Y Activities for Both Glass and Resin Microsphere Devices
    Silvano Gnesin, Justin K. Mikell, Maurizio Conti, John O. Prior, Thomas Carlier, Thiago V.M. Lima and Yuni K. Dewaraja
    Journal of Nuclear Medicine May 1, 2023, 64 (5) 825-828; DOI: https://doi.org/10.2967/jnumed.122.264458
  • You have access
    Three-Time-Point PET Analysis of 68Ga-FAPI-46 in a Variety of Cancers
    Mahnoosh Naeimi, Peter L. Choyke, Katharina Dendl, Yuriko Mori, Fabian Staudinger, Tadashi Watabe, Stefan A. Koerber, Manuel Röhrich, Jürgen Debus, Clemens Kratochwil, Uwe Haberkorn and Frederik L. Giesel
    Journal of Nuclear Medicine April 1, 2023, 64 (4) 618-622; DOI: https://doi.org/10.2967/jnumed.122.264941
  • Preclinical Evaluation of <sup>89</sup>Zr-Desferrioxamine-Bexmarilimab, a Humanized Antibody Against Common Lymphatic Endothelial and Vascular Endothelial Receptor-1, in a Rabbit Model of Renal Fibrosis
    Open Access
    Preclinical Evaluation of 89Zr-Desferrioxamine-Bexmarilimab, a Humanized Antibody Against Common Lymphatic Endothelial and Vascular Endothelial Receptor-1, in a Rabbit Model of Renal Fibrosis
    Olli Moisio, Jenni Virta, Emrah Yatkin, Heidi Liljenbäck, Senthil Palani, Riikka Viitanen, Maxwell W.G. Miner, Vesa Oikonen, Tuula Tolvanen, Danielle J. Vugts, Pekka Taimen, Xiang-Guo Li, Maija Hollmén, Sirpa Jalkanen and Anne Roivainen
    Journal of Nuclear Medicine April 1, 2023, 64 (4) 555-560; DOI: https://doi.org/10.2967/jnumed.122.264725
  • Phase III Study of <sup>18</sup>F-PSMA-1007 Versus <sup>18</sup>F-Fluorocholine PET/CT for Localization of Prostate Cancer Biochemical Recurrence: A Prospective, Randomized, Crossover Multicenter Study
    Open Access
    Phase III Study of 18F-PSMA-1007 Versus 18F-Fluorocholine PET/CT for Localization of Prostate Cancer Biochemical Recurrence: A Prospective, Randomized, Crossover Multicenter Study
    Pierre Olivier, Anne-Laure Giraudet, Andrea Skanjeti, Charles Merlin, Pierre Weinmann, Ines Rudolph, Alexander Hoepping and Mathieu Gauthé
    Journal of Nuclear Medicine April 1, 2023, 64 (4) 579-585; DOI: https://doi.org/10.2967/jnumed.122.264743
  • Novel <sup>68</sup>Ga-FAPI PET/CT Offers Oncologic Staging Without COVID-19 Vaccine–Related Pitfalls
    Open Access
    Novel 68Ga-FAPI PET/CT Offers Oncologic Staging Without COVID-19 Vaccine–Related Pitfalls
    Tristan T. Demmert, Ines Maric, Kelsey L. Pomykala, Katharina Lueckerath, Jens Siveke, Benedikt M. Schaarschmidt, Rainer Hamacher, Ken Herrmann and Wolfgang P. Fendler
    Journal of Nuclear Medicine March 1, 2023, 64 (3) 368-371; DOI: https://doi.org/10.2967/jnumed.122.264872
  • PSMA-Directed Imaging and Therapy of Salivary Gland Tumors: A Single-Center Retrospective Study
    You have access
    PSMA-Directed Imaging and Therapy of Salivary Gland Tumors: A Single-Center Retrospective Study
    Caner Civan, Stefan Kasper, Christoph Berliner, Pedro Fragoso-Costa, Viktor Grünwald, Michael Pogorzelski, Benedikt Michael Schaarschmidt, Stephan Lang, David Kersting, Michael Nader, Katharina Lückerath, Ken Herrmann, Wolfgang P. Fendler and Manuel Weber
    Journal of Nuclear Medicine March 1, 2023, 64 (3) 372-378; DOI: https://doi.org/10.2967/jnumed.122.264342
  • PET Imaging of Fibroblast Activation Protein in Various Types of Cancer Using <sup>68</sup>Ga-FAP-2286: Comparison with <sup>18</sup>F-FDG and <sup>68</sup>Ga-FAPI-46 in a Single-Center, Prospective Study
    You have access
    PET Imaging of Fibroblast Activation Protein in Various Types of Cancer Using 68Ga-FAP-2286: Comparison with 18F-FDG and 68Ga-FAPI-46 in a Single-Center, Prospective Study
    Yizhen Pang, Liang Zhao, Tinghua Meng, Weizhi Xu, Qin Lin, Hua Wu, Jingjing Zhang, Xiaoyuan Chen, Long Sun and Haojun Chen
    Journal of Nuclear Medicine March 1, 2023, 64 (3) 386-394; DOI: https://doi.org/10.2967/jnumed.122.264544

Pages

  • Previous
  • Next
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
  • …
  • 32
SNMMI

© 2023 Journal of Nuclear Medicine

Powered by HighWire